Informaçao sobre o Autor

Mortada, V. V.

Edição	Seção	Título	Arquivo
Volume 30, Nº 6/7 (2023)	Clinical experience	Treatment of locally advanced (T2-3N0-1M0) and early (T1-2N0M0) HER2-positive breast cancer (clinical experience)
Volume 30, Nº 6/7 (2023)	Original articles	Evaluation of long-term results of treatment of patients with residual tumors (including those with minimal forms of ypT1abN0), with pathomorphological complete response (pCR) after neoadjuvant systemic therapy, with primary minimal breast cancer (pT1abN0M0)
Volume 30, Nº 6/7 (2023)	Original articles	Analysis of the effectiveness of various neoadjuvant chemotherapy regimens in patients with T1-3N1-3M0 I–IIIC stage locally advanced breast cancer
Volume 32, Nº 3 (2025)	Reviews	Prognostic value of low HER2 expression in patients with early breast cancer